Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-10-26

Clinical Trial Update: Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating irbesartan in combination with amlodipine for hypertension in patients inadequately controlled on amlodipine monotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Irbesartan (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 3 | Status: COMPLETED